These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 11815604)

  • 1. Elucidation of the molecular mechanism during the early events in immunoglobulin light chain amyloid fibrillation. Evidence for an off-pathway oligomer at acidic pH.
    Souillac PO; Uversky VN; Millett IS; Khurana R; Doniach S; Fink AL
    J Biol Chem; 2002 Apr; 277(15):12666-79. PubMed ID: 11815604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of association state and conformational stability on the kinetics of immunoglobulin light chain amyloid fibril formation at physiological pH.
    Souillac PO; Uversky VN; Millett IS; Khurana R; Doniach S; Fink AL
    J Biol Chem; 2002 Apr; 277(15):12657-65. PubMed ID: 11815605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural transformations of oligomeric intermediates in the fibrillation of the immunoglobulin light chain LEN.
    Souillac PO; Uversky VN; Fink AL
    Biochemistry; 2003 Jul; 42(26):8094-104. PubMed ID: 12834361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A model for amyloid fibril formation in immunoglobulin light chains based on comparison of amyloidogenic and benign proteins and specific antibody binding.
    Khurana R; Souillac PO; Coats AC; Minert L; Ionescu-Zanetti C; Carter SA; Solomon A; Fink AL
    Amyloid; 2003 Jun; 10(2):97-109. PubMed ID: 12964417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Partially folded intermediates as critical precursors of light chain amyloid fibrils and amorphous aggregates.
    Khurana R; Gillespie JR; Talapatra A; Minert LJ; Ionescu-Zanetti C; Millett I; Fink AL
    Biochemistry; 2001 Mar; 40(12):3525-35. PubMed ID: 11297418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thermodynamic and fibril formation studies of full length immunoglobulin light chain AL-09 and its germline protein using scan rate dependent thermal unfolding.
    Blancas-Mejía LM; Horn TJ; Marin-Argany M; Auton M; Tischer A; Ramirez-Alvarado M
    Biophys Chem; 2015 Dec; 207():13-20. PubMed ID: 26263488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences in Protein Concentration Dependence for Nucleation and Elongation in Light Chain Amyloid Formation.
    Blancas-Mejía LM; Misra P; Ramirez-Alvarado M
    Biochemistry; 2017 Feb; 56(5):757-766. PubMed ID: 28074646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of amyloid fibril formation by two closely related immunoglobulin light chain variable domains.
    Martin DJ; Ramirez-Alvarado M
    Amyloid; 2010 Sep; 17(3-4):129-36. PubMed ID: 21077798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MAK33 antibody light chain amyloid fibrils are similar to oligomeric precursors.
    Hora M; Sarkar R; Morris V; Xue K; Prade E; Harding E; Buchner J; Reif B
    PLoS One; 2017; 12(7):e0181799. PubMed ID: 28746363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of methionine oxidation on the structural properties, conformational stability, and aggregation of immunoglobulin light chain LEN.
    Hu D; Qin Z; Xue B; Fink AL; Uversky VN
    Biochemistry; 2008 Aug; 47(33):8665-77. PubMed ID: 18652490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of membranes on the in vitro fibrillation of an amyloidogenic light-chain variable-domain SMA.
    Meng X; Fink AL; Uversky VN
    J Mol Biol; 2008 Sep; 381(4):989-99. PubMed ID: 18619464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural characterization of the partially folded intermediates of an immunoglobulin light chain leading to amyloid fibrillation and amorphous aggregation.
    Qin Z; Hu D; Zhu M; Fink AL
    Biochemistry; 2007 Mar; 46(11):3521-31. PubMed ID: 17315948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The amyloid fibrils of the constant domain of immunoglobulin light chain.
    Yamamoto K; Yagi H; Lee YH; Kardos J; Hagihara Y; Naiki H; Goto Y
    FEBS Lett; 2010 Aug; 584(15):3348-53. PubMed ID: 20580354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recruitment of Light Chains by Homologous and Heterologous Fibrils Shows Distinctive Kinetic and Conformational Specificity.
    Blancas-Mejía LM; Ramirez-Alvarado M
    Biochemistry; 2016 May; 55(21):2967-78. PubMed ID: 27158939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aggregation of Full-length Immunoglobulin Light Chains from Systemic Light Chain Amyloidosis (AL) Patients Is Remodeled by Epigallocatechin-3-gallate.
    Andrich K; Hegenbart U; Kimmich C; Kedia N; Bergen HR; Schönland S; Wanker E; Bieschke J
    J Biol Chem; 2017 Feb; 292(6):2328-2344. PubMed ID: 28031465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surface-catalyzed amyloid fibril formation.
    Zhu M; Souillac PO; Ionescu-Zanetti C; Carter SA; Fink AL
    J Biol Chem; 2002 Dec; 277(52):50914-22. PubMed ID: 12356747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heat-induced native dimerization prevents amyloid formation by variable domain from immunoglobulin light-chain REI.
    Nawata M; Tsutsumi H; Kobayashi Y; Unzai S; Mine S; Nakamura T; Uegaki K; Kamikubo H; Kataoka M; Hamada D
    FEBS J; 2017 Sep; 284(18):3114-3127. PubMed ID: 28736891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism of formation of amyloid protofibrils of barstar from soluble oligomers: evidence for multiple steps and lateral association coupled to conformational conversion.
    Kumar S; Mohanty SK; Udgaonkar JB
    J Mol Biol; 2007 Apr; 367(4):1186-204. PubMed ID: 17292913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of two principal amyloid-driving segments in variable domains of Ig light chains in systemic light-chain amyloidosis.
    Brumshtein B; Esswein SR; Sawaya MR; Rosenberg G; Ly AT; Landau M; Eisenberg DS
    J Biol Chem; 2018 Dec; 293(51):19659-19671. PubMed ID: 30355736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kinetic control in protein folding for light chain amyloidosis and the differential effects of somatic mutations.
    Blancas-Mejía LM; Tischer A; Thompson JR; Tai J; Wang L; Auton M; Ramirez-Alvarado M
    J Mol Biol; 2014 Jan; 426(2):347-61. PubMed ID: 24157440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.